Additive Manufacturing is already being used successfully in many areas of the pharmaceutical industry – from spare parts to format parts to personalized medicines, 3D printing is already widely used, but so far often behind closed doors.
This working group offers all players in the pharmaceutical value chain the opportunity not only to communicate their ideas on how AM can be integrated into pharmaceutical processes, but also to jointly advance and implement them.
Together with leading pharma and tech partners including Takeda, IOI Oleo GmbH, Replique, ARBURG Additive Manufacturing, BioMed Center Innovation gGmbH and more, we’ll discuss the global landscape, best practices and technologies.
Focusing on the manufacturing of medications, format parts and tools in the pharma industry.
Almost all of them have developed concrete application possibilities, but often do not present them to the public.
Involve all stakeholders through education, training and open mindset to develop a win-win solution for all stakeholders in the value chain
Develop a common platform that will be used for communication, data exchange, education, etc. to ultimately establish a scalable process regarding IP rights, regulatory and liability issues, and certifications
Review and define product specifications, moving away from over-engineering
